DK3004080T3 - Triazolforbindelser og deres anvendelse som gamma-sekretase-modulatorer - Google Patents
Triazolforbindelser og deres anvendelse som gamma-sekretase-modulatorer Download PDFInfo
- Publication number
- DK3004080T3 DK3004080T3 DK14728533.2T DK14728533T DK3004080T3 DK 3004080 T3 DK3004080 T3 DK 3004080T3 DK 14728533 T DK14728533 T DK 14728533T DK 3004080 T3 DK3004080 T3 DK 3004080T3
- Authority
- DK
- Denmark
- Prior art keywords
- gamma secretase
- secretase modulators
- triazol compounds
- triazol
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1350684 | 2013-06-04 | ||
| PCT/EP2014/061501 WO2014195322A1 (en) | 2013-06-04 | 2014-06-03 | Triazole compounds and their use as gamma secretase modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3004080T3 true DK3004080T3 (da) | 2019-01-02 |
Family
ID=50896282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14728533.2T DK3004080T3 (da) | 2013-06-04 | 2014-06-03 | Triazolforbindelser og deres anvendelse som gamma-sekretase-modulatorer |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9718805B2 (da) |
| EP (1) | EP3004080B1 (da) |
| JP (1) | JP6396438B2 (da) |
| CN (1) | CN105263922B (da) |
| DK (1) | DK3004080T3 (da) |
| ES (1) | ES2701810T3 (da) |
| WO (1) | WO2014195322A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10603311B2 (en) * | 2015-02-25 | 2020-03-31 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to improve cognitive function and for treating Alzheimer's disease |
| US11471449B2 (en) | 2015-02-25 | 2022-10-18 | Prilenia Neurotherapeutics Ltd. | Use of pridopidine to improve cognitive function and for treating Alzheimer's disease |
| US10576125B2 (en) | 2016-10-31 | 2020-03-03 | Hough Ear Institute | Methods for enhancing synaptogenesis and neuritogenesis |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20030312A1 (it) | 2003-02-21 | 2004-08-22 | Chiesi Farma Spa | Derivati di acidi 2-fenil-2-alchil-acetici per il trattamento della malattia di alzheimer. |
| WO2005013985A1 (en) | 2003-08-07 | 2005-02-17 | Merck Sharp & Dohme Limited | Treatment for alzheimer's disease and related conditions |
| WO2005054193A1 (en) | 2003-12-03 | 2005-06-16 | Merck & Co. Inc. | 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions |
| TWI335816B (en) | 2004-05-26 | 2011-01-11 | Eisai R&D Man Co Ltd | Cinnamide compound |
| WO2007125364A1 (en) | 2006-04-26 | 2007-11-08 | Merck Sharp & Dohme Limited | Piperidines and related compounds for treatment of alzheimer’s disease |
| JPWO2007135969A1 (ja) | 2006-05-19 | 2009-10-01 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ウレア系−シンナミド誘導体 |
| JP2009184924A (ja) | 2006-05-31 | 2009-08-20 | Eisai R & D Management Co Ltd | 生物学的試薬用化合物 |
| JP2010518080A (ja) | 2007-02-08 | 2010-05-27 | メルク・シャープ・エンド・ドーム・コーポレイション | 治療薬 |
| CA2676920A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperidine derivatives |
| US20100204230A1 (en) | 2007-02-12 | 2010-08-12 | Peter Blurton | Piperazine derivatives for treatment of ad and related conditions |
| US8242150B2 (en) | 2007-06-13 | 2012-08-14 | Merck Sharp & Dohme Corp. | Triazole derivatives for treating alzheimer'S disease and related conditions |
| EP2185522A1 (en) | 2007-08-06 | 2010-05-19 | Schering Corporation | Gamma secretase modulators |
| MX2010002674A (es) * | 2007-09-06 | 2010-03-25 | Schering Corp | Moduladores de gamma secretasa. |
| CN101910142B (zh) | 2008-01-11 | 2013-07-10 | 弗·哈夫曼-拉罗切有限公司 | β-淀粉状蛋白的调节剂 |
| RU2010137300A (ru) | 2008-02-22 | 2012-03-27 | Ф. Хоффманн-Ля Рош Аг (Ch) | Модуляторы бета-амилоида |
| CA2742897A1 (en) | 2008-11-06 | 2010-05-14 | Astrazeneca Ab | Modulators of amyloid beta. |
| BRPI0921348A2 (pt) | 2008-11-10 | 2019-09-24 | Hoffmann La Roche | moduladores heterocíclicos da gama secretase |
| TW201030002A (en) | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
| UY32622A (es) | 2009-05-12 | 2010-12-31 | Astrazeneca Ab | Nuevos compuestos para el tratamiento de patologías relacionadas con ab(beta) |
| CA2778517A1 (en) | 2009-07-15 | 2011-01-20 | Janssen Pharmaceuticals, Inc. | Substituted triazole and imidazole derivatives as gamma secretase modulators |
| TWI468402B (zh) | 2009-07-31 | 2015-01-11 | 必治妥美雅史谷比公司 | 降低β－類澱粉生成之化合物 |
| NZ601150A (en) | 2010-01-15 | 2014-06-27 | Janssen Pharmaceuticals Inc | Novel substituted bicyclic triazole derivatives as gamma secretase modulators |
| US20110190269A1 (en) * | 2010-02-01 | 2011-08-04 | Karlheinz Baumann | Gamma secretase modulators |
| TW201206946A (en) | 2010-07-15 | 2012-02-16 | Bristol Myers Squibb Co | Compounds for the reduction of beta-amyloid production |
-
2014
- 2014-06-03 DK DK14728533.2T patent/DK3004080T3/da active
- 2014-06-03 CN CN201480031629.0A patent/CN105263922B/zh not_active Expired - Fee Related
- 2014-06-03 WO PCT/EP2014/061501 patent/WO2014195322A1/en active Application Filing
- 2014-06-03 EP EP14728533.2A patent/EP3004080B1/en not_active Not-in-force
- 2014-06-03 ES ES14728533T patent/ES2701810T3/es active Active
- 2014-06-03 US US14/895,519 patent/US9718805B2/en active Active
- 2014-06-03 JP JP2016517274A patent/JP6396438B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20160108022A1 (en) | 2016-04-21 |
| EP3004080A1 (en) | 2016-04-13 |
| WO2014195322A1 (en) | 2014-12-11 |
| CN105263922A (zh) | 2016-01-20 |
| JP6396438B2 (ja) | 2018-09-26 |
| US9718805B2 (en) | 2017-08-01 |
| JP2016520636A (ja) | 2016-07-14 |
| ES2701810T3 (es) | 2019-02-26 |
| CN105263922B (zh) | 2018-08-17 |
| EP3004080B1 (en) | 2018-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190483T1 (hr) | Ror gama (rory) modulatori | |
| HK1255229A1 (zh) | 用作RORγ調節劑的經過取代的四氫喹啉酮化合 | |
| DK3052485T3 (da) | Heterocykliske forbindelser og anvendelser deraf | |
| DK3277681T3 (da) | Imidazolonylquinoliner og deres anvendelse som atm-kinaseinhibitorer | |
| DK3363438T3 (da) | Substituerede 2-azabicykler og deres anvendelse som orexinreceptormodulatorer | |
| DK3381917T3 (da) | Imidazopyridinforbindelser og anvendelser deraf | |
| DK3149001T3 (da) | Hidtil ukendte pyrazolopyrimidinderivater og deres anvendelse som MALT1-hæmmere | |
| DK3608325T3 (da) | Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse | |
| DK2763112T3 (da) | Dynamisk nødhjælp | |
| DK3143011T3 (da) | Deutererede heterocykliske forbindelser og deres anvendelse som billeddannende stoffer | |
| DK2968173T3 (da) | Heterocykliske forbindelser og anvendelser deraf | |
| DK3063144T3 (da) | Antiparasitære og pesticid-isoxazolinforbindelser | |
| DK2943549T3 (da) | Synergistisk h2s-scavenger-sammensætning | |
| DK3030549T3 (da) | Pyridazinonforbindelser og anvendelser deraf | |
| DK3077467T3 (da) | Sikkativsammensætning og anvendelse deraf | |
| BR112016010669A2 (pt) | composição desinfetante | |
| IL244930A0 (en) | Quinolinyls are modulators of ror gamma t | |
| DK3126361T3 (da) | Chromen og 1,1a,2,7b-tetrahydrocyclopropa[c]chromen- pyridopyrazindioner som gamma-sekretase-modulatorer | |
| DK2958926T5 (da) | Epidithiodioxopiperazinforbindelse eller derivater deraf og anvendelse deraf | |
| DK3066089T3 (da) | Substituerede n-acetyl-l-cysteinderivater og relaterede forbindelser | |
| DK2986618T3 (da) | Organiske anion-lithium-ion-co-krystalforbindelser og sammensætninger | |
| SG11201604755QA (en) | Substituted dihydro-benzimidazole compounds as ror gamma modulators | |
| PL3004079T3 (pl) | Związki pirymidyny i ich zastosowanie jako modulatorów sekretazy gamma | |
| IL243957A0 (en) | Formulations containing gamma secretase modulators | |
| DK3004080T3 (da) | Triazolforbindelser og deres anvendelse som gamma-sekretase-modulatorer |